Video Experimental Relacionado
Updated: Jul 16, 2026
Confocal Time Lapse Imaging as an Efficient Method for the Cytocompatibility Evaluation of Dental Composites
Published on: November 9, 2014
Biocompatibilidad de Compuestos Biodegradables de Fe-AZ31 Fabricados por Adición para Aplicaciones de Implantes
Xue Dong1, Samuel Medina1, Sai Pratyush Akula2
1Laboratory of Bioregenerative Medicine & Surgery, Department of Surgery, Division of Plastic Surgery, Weill Cornell Medical College, New York, New York 10065, United States.
Purpose:
Metallic plating systems composed of titanium and its alloys remain the standard treatment for craniofacial bony fixation but may require secondary removal due to infection, implant migration, or discomfort. Absorbable polymeric alternatives reduce those risks but lack sufficient strength for load-bearing applications. Thus, biodegradable metallic implants may eliminate complications and secondary procedures while maintaining the structural integrity. Our previous work demonstrated the fabrication of immiscible Fe-AZ31 composites via additive manufacturing with improved degradation kinetics over pure iron. This study aimed to evaluate the in vitro and in vivo biocompatibility of Fe-AZ31 composites for potential craniofacial fixation applications.
Methods:
Pure iron (Fe), magnesium (Al-Mg-Zn) alloy (AZ31), and Fe-AZ31 samples were fabricated for extract-based cytotoxicity testing using HFF-1 fibroblasts, L929 fibroblasts, and hFOB osteoblasts. Metal extracts were prepared at a 3 cm2/mL surface-to-volume ratio in complete media at 37 °C and cell viability was measured by live/dead assay after 24 and 72 h exposure. For in vivo evaluation, Fe-AZ31, Fe, and titanium (Ti) plates were implanted subcutaneously in wild type mice for 6 weeks and 3 and 6 months. Implant degradation, histologic response, hematology, and serum biochemistry were assessed.
Results:
Fe-AZ31 extracts demonstrated ≥70% cell viability across all cell types at both time points with normal cell morphology and adhesion, whereas AZ31 extracts caused marked cytotoxicity associated with pronounced alkalization (pH 10.53). In vivo, Fe-AZ31 implants exhibited gradual surface corrosion accompanied by mild, transient inflammation and minimal capsule formation over time. No systemic toxicity was observed. Hematology and serum biochemistry remained within the physiological limits.
Conclusion:
Additively manufactured Fe-AZ31 composites demonstrate acceptable cytobiocompatibility and favorable tissue responses, supporting their development as bioresorbable metallic fixation devices for craniofacial reconstruction.
